STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Liquidia (LQDA) Insider Files Form 144 to Sell 70,000 Shares

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Form 144 notice for Liquidia Corporation (LQDA) shows a proposed sale of 70,000 common shares through Morgan Stanley Smith Barney at an aggregate market value of $1,937,600, with an approximate sale date of 09/02/2025 on NASDAQ. The shares were acquired in three tranches: 8,315 via an Employee Stock Purchase Plan on 08/31/2022, 7,650 as Performance Stock Units on 11/10/2021, and 54,035 as Restricted Stock Units on 07/11/2024; payment where applicable was in cash or recorded as N/A. The filing lists two recent sales by the same seller, totaling 11,453 shares for gross proceeds of $181,453.48. The filer represents they are unaware of undisclosed material adverse information.

Positive

  • Full Rule 144 disclosure provided including acquisition dates, grant types, and broker information
  • Proposed sale documented with aggregate market value ($1,937,600) and targeted sale date (09/02/2025)

Negative

  • Insider is selling 70,000 shares, which may be viewed negatively by some investors
  • Recent prior sales of 11,453 shares in 2025 suggest ongoing dispositions by the same seller

Insights

TL;DR: Routine insider sale notice for 70,000 shares valued at $1.94M; not obviously material relative to share count.

The filing documents a proposed sale by an insider through a broker, with the total 70,000 shares acquired across ESPP, PSUs, and RSUs. The proposed sale value of $1,937,600 represents a small fraction of the reported 86,091,454 shares outstanding (approximately 0.081%). Two prior sales this year total 11,453 shares for $181,453.48, indicating prior partial dispositions. This is a standard Rule 144 disclosure and, by itself, does not provide evidence of company operational changes or material adverse information.

TL;DR: Filing appears compliant with Rule 144 disclosure requirements; signatures and attestations are included.

The notice includes acquisition dates, nature of grant types (ESPP, PSUs, RSUs), payment information, broker details, and recent sales history, aligning with Rule 144 disclosure norms. The signer affirms no undisclosed material adverse information. There is no indication in this document of trading-plan dates or 10b5-1 adoption. From a compliance perspective, the filing contains the expected elements to permit secondary market sale under Rule 144.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does Liquidia Corporation's (LQDA) Form 144 report?

The Form 144 reports a proposed sale of 70,000 common shares via Morgan Stanley Smith Barney with an aggregate market value of $1,937,600 and an approximate sale date of 09/02/2025.

Who is the seller named in the Form 144 for LQDA?

The seller listed for recent transactions is Scott Moomaw, with two prior sales on 06/04/2025 and 07/14/2025 totaling 11,453 shares.

How were the 70,000 shares acquired according to the filing?

The shares were acquired as 8,315 via an ESPP (08/31/2022), 7,650 as PSUs (11/10/2021), and 54,035 as RSUs (07/11/2024).

What portion of outstanding shares does the proposed sale represent?

The filing lists 86,091,454 shares outstanding; 70,000 shares represent approximately 0.081% of that total.

Which broker is handling the proposed sale for LQDA shares?

The broker named in the filing is Morgan Stanley Smith Barney LLC Executive Financial Services located at 1 New York Plaza, New York, NY.
Liquidia Corporation

NASDAQ:LQDA

LQDA Rankings

LQDA Latest News

LQDA Latest SEC Filings

LQDA Stock Data

2.96B
74.36M
13.61%
70.58%
19.88%
Biotechnology
Pharmaceutical Preparations
Link
United States
MORRISVILLE